• OPEN AN ACCOUNT
Indian Indices
Sensex
83,570.35 187.64
( 0.23%)
Global Indices
Nasdaq
49,379.59 -83.86
(-0.17%)
Dow Jones
6,960.70 -4.77
(-0.07%)
Hang Seng
53,996.71 -113.79
(-0.21%)
Nikkei 225
10,219.48 -19.46
(-0.19%)
Forex
USD-INR
90.32 0.07
(0.08%)
EUR-INR
104.98 -0.13
(-0.12%)
GBP-INR
121.10 -0.20
(-0.16%)
JPY-INR
0.57 0.00
(0.21%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
140.8744507
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
0
16673.13
EPS(TTM)
Face Value()
Div & Yield %
0
1
0.48
 

steadfast corporation ltd
JHS Svendgaard Laboratories reports consolidated net loss of Rs 0.20 crore in the September 2025 quarter
Nov 15,2025
Net Loss of JHS Svendgaard Laboratories reported to Rs 0.20 crore in the quarter ended September 2025 as against net loss of Rs 10.32 crore during the previous quarter ended September 2024. Sales rose 13.21% to Rs 22.28 crore in the quarter ended September 2025 as against Rs 19.68 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales22.2819.68 13
OPM %4.08-4.32 -
PBDT1.85-0.09 LP
PBT-0.02-2.07 99
NP-0.20-10.32 98